Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

RELMADA THERAPEUTICS, INC. (RLMD)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Jun-30-19Jun-30-18Jun-30-17Jun-30-16
   10-K10-K10-K10-K10-K10-K10-K10-K
Cash flows from operating activities          
Net loss  -157.0-125.8   -9.0-6.3-3.0
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Stock-based compensation  44.240.520.83.21.20.50.71.2
    Gain on settlement of fees  -6.4       
    Realized loss (gain) on short-term investments  0.60.6      
    Change in operating assets and liabilities:          
        Lease payment receivable  0.10.10.10.10.10.1  
        Other receivables      -0.20.20.0-0.2
        Prepaid expenses and other assets  7.3-10.4-0.50.50.30.00.4 
        Accounts payable  0.42.87.80.20.20.2-0.70.4
        Accrued expenses  3.3-0.43.4-0.61.20.2-0.30.2
            Net cash (used in) operating activities  -103.8-91.9-27.8-12.1-10.5-6.0-6.5-13.1
   
Cash flows from investing activities          
Purchase of short-term investments  -47.3-223.0-182.1     
Sale of short-term investments  67.0168.9      
    Net cash provided by (used in) investing activities  19.7-54.1-34.4-80.2 0.00.0-0.6
   
Cash flows from financing activities          
Proceeds from issuance of common stock, net  0.0184.619.8     
Proceeds from options exercised for common stock    0.7     
Proceeds from warrants exercised for common stock    8.1     
    Net cash provided by financing activities  45.0187.928.5126.117.56.5-0.3-0.3
   
Cash paid during the period for:          
    Interest          
    Income Tax          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy